Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

7 treatments under study, led by Photosensitive Hydrogel

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
Phase 1 (1)
Phase 2 (1)

Trial Status

Completed1
Unknown1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07499791Phase 2RecruitingPrimary

Absorbable Drug-Eluting Lacrimal Sac Stent for Recurrent Chronic Dacryocystitis

NCT06551766Not ApplicableUnknownPrimary

The Application of Photosensitive Hydrogel in Intranasal Endoscopic Dacryocystorhinostomy

NCT06175676Phase 1Completed

Safety and Efficacy of Thermosensitive Hydroxybutyl Chitosan and 5-fluorouracil Assisted Endoscopic Dacryocystorhinostomy in the Treatment of Chronic Dacryocystitis

Showing all 3 trials

Research Network

Common Treatments

  • Photosensitive Hydrogel1
  • 60 Absorbable Stitches1
  • Absorbable Lacrimal Sac Drugeluting Stent1
  • Fluorouracil1
  • Gelatin Sponge Sheet1

Active Sponsors

  • Beijing Tongren Hospital1
  • Eye & ENT Hospital of Fudan University1
  • Tianjin Medical University Eye Hospital1

Top Investigators

Related Conditions

  • Dacryocystorhinostomy1
  • Hydroxybutyl Chitosan1
  • Fluorouracil1

Activity Timeline